This release brings a major update to the user interface (UI) in CAT4. The UI updates include:
- New Graph types
- Consistent colour scheme throughout all graphs
- Traffic light scheme applied where relevant
- Simplified logon and improved user interface
Other changes:
- Update to requirements to .Net 4.5.2 from .Net 4.0
- Added lipid modifying drugs:
- Alirocumab and Evolocumab
- Added diabetes drugs:
- Ertugliflozin (Steglataro)
- Ertugliflozin/sitagliptin (Steglujan)
- Ertugliflozin/metformin (Brand name: Segluromet)
- Added heart medication Abisart
- Redesign for GoShare functionality
- Changed CV Event Risk report to provide more meaningful categories
- Removed Pap Smear report as it is now replaced by cervical screening
- Added new category ‘opted out/no longer required’ to cervical screening report (MD/BP only)
- Some minor fixes for PIP QI reports
- Performance enhancements and numerous minor fixes